Novo Nordisk executives overlooked warnings ahead of Wegovy's launch, leading to supply issues, high costs, and challenges competing with Eli Lilly's Zepbound.

Leonardo DiCaprio was among Jeff Bezos' wedding guests that netizen's pointed out as potentially using ozempic, a weight loss ...

Khloé Kardashian began her weight loss journey amid her 2013 divorce from Lamar Odom Khloé Kardashian first started working ...

A Chinese company has developed a new diabetes drug that could become a strong competitor to Ozempic and Monjauro as a weight ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

SHOPPING: If you're tired of struggling to lose weight, you may just need a little help - and Hers makes it simpler than ever ...

A drug that can be taken orally could soon rival the likes of Ozempic for treating type 2 diabetes and obesity, according to ...

Anyone who saw the epic carpet fail that was Jeff Bezos's wedding at the weekend will realise that, although it may sound ...

The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...

A man who stopped using Ozempic after shedding 112 pounds has revealed how he's managed to maintain his weight. The drug, ...

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

GLP-1 drugs like Ozempic® and Zepbound®, have gained significant attention in recent years for treating both diabetes and ...